原始名称记载: NEOCANNBIO CO., LTD.; KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY

The present disclosure relates to a pharmaceutical composition including cannabinoids as active ingredients, for preventing or treating degenerative brain diseases, and use thereof. The present disclosure has confirmed that when a composition including cannabinoids is used for treatment, a remarkably excellent Alzheimer's treatment or prevention efficacy is exhibited, and thus, the treatment effect on degenerative brain diseases such as Alzheimer's may be enhanced by using the composition.